Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.